ArticleNature communications2022

Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma.

Yuen Lam Dora Ng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.